Clinical relevance of antithrombin deficiencies
Mammen, E.F.
Seminars in Hematology 32(4 Suppl 2: 2-6; Discussion 7
1995
ISSN/ISBN: 0037-1963 PMID: 8821204 Document Number: 452358
Document emailed within 1 workday
Related Documents
Masuda, H.; Tsuji, H.; Nakahara, Y.; Nishimura, H.; Kasahara, T.; Sugano, T.; Nakagawa, M. 1997: Genetic analysis of congenital antithrombin deficiencies Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 104: 187-194Mielot, F.; Danel, P.; Boyer, C.; Coulombel, L.; Dommergues, J.P.; Tchernia, G.; Larrieu, M.J. 1987: Acquired deficiencies in antithrombin IIi and C protein during treatment with L-asparaginase Archives Francaises de Pediatrie 44(3): 161-165
Rohner, F.; Northrop-Clewes, C.; Tschannen, A.B.; Bosso, P.E.; Kouassi-Gohou, V.ér.; Erhardt, J.G.; Bui, M.; Zimmermann, M.B.; Mascie-Taylor, C.G.N. 2014: Prevalence and public health relevance of micronutrient deficiencies and undernutrition in pre-school children and women of reproductive age in Côte d'Ivoire, West Africa Public Health Nutrition 17(9): 2016-2028
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Vinazzer, H.; Bergmann, H.; Blauhut, B. 1984: The clinical value of antithrombin IIi Wiener Medizinische Wochenschrift 134(12): 279-283
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Andreenko, G.V.; Poliantseva, L.R.; Podorol'skaia, L.V. 1980: Antithrombin IIi and its role in clinical pathology Terapevticheskii Arkhiv 52(2): 141-145
Inai, S. 1988: Clinical study of congenital complement deficiencies and abnormalities Nihon Rinsho. Japanese Journal of Clinical Medicine 46(9): 2011-2016
Larracilla-Alegre, J.; Pérez-Arteaga, L.; Juárez-Frausto, A.; Escárcega, S. 1974: Rachitism deficiencies. Epidemiologic and clinical aspects of 70 cases Gaceta Medica de Mexico 108(6): 373-382
Bergoz, R. 1980: Disaccharidase deficiencies. Clinical, nutritional and therapeutic aspects Revue Medicale de la Suisse Romande 100(1): 57-70
Takahashi, K.; Sakuragawa, N. 1982: Family of abnormal antithrombin III. Clinical studies Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 50: 137-145
Del Rosso, J.Q. 2013: What more can we learn about acne and rosacea? Just keep reading, questioning, and searching for clinical relevance beyond the limitations of clinical trials Journal of Drugs in Dermatology: Jdd 12(6): 609-610
Ermolina, L.A.; Baryshnikov, V.A.; Gorbachevskaia, N.L.; Turova, N.F. 1982: Correlations between biological and clinical indices in children with intellectual deficiencies Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 82(3): 59-62
Rubinowitz, M.J.; Ford, C. 1977: Familial antithrombin IIi deficiency. An important clinical entity Rocky Mountain Medical Journal 74(5): 246-249
Berkovskiĭ, A.L.; Sergeeva, E.V.; Kartoshkina, A.V.; Suvorov, A.V. 2006: Standardization of coagulologic technique for antithrombin III estimation and its clinical application Klinicheskaia Laboratornaia Diagnostika 2006(8): 29-30
Woo, K.T. 1985: Galloway memorial lecture. Platelet injury and antithrombin III in clinical nephrology Annals of the Academy of Medicine Singapore 14(2): 394-403